Reporting of sodium-glucose cotransporter 2 (SGLT2) inhibitor trial safety: an observational analysis of ClinicalTrials.gov registrations and journal publications
- DOI
- 10.1016/j.jclinepi.2026.112227
- Published
- 2026-06
- Container
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jclinepi.2026.112227,
title = {Reporting of sodium-glucose cotransporter 2 (SGLT2) inhibitor trial safety: an observational analysis of ClinicalTrials.gov registrations and journal publications},
author = {Fran Šaler and Ivan Paladin and Ivana Blažeković and Ema Boras and Ružica Tokalić and Marin Viđak and Livia Puljak},
year = {2026},
journal = {Journal of Clinical Epidemiology},
doi = {10.1016/j.jclinepi.2026.112227},
url = {https://doi.org/10.1016/j.jclinepi.2026.112227}
}RIS
TY - JOUR TI - Reporting of sodium-glucose cotransporter 2 (SGLT2) inhibitor trial safety: an observational analysis of ClinicalTrials.gov registrations and journal publications AU - Fran Šaler AU - Ivan Paladin AU - Ivana Blažeković AU - Ema Boras AU - Ružica Tokalić AU - Marin Viđak AU - Livia Puljak PY - 2026 JO - Journal of Clinical Epidemiology DO - 10.1016/j.jclinepi.2026.112227 UR - https://doi.org/10.1016/j.jclinepi.2026.112227 ER -
APA
Šaler, F., Paladin, I., Blažeković, I., Boras, E., Tokalić, R., Viđak, M., & Puljak, L. (2026). Reporting of sodium-glucose cotransporter 2 (SGLT2) inhibitor trial safety: an observational analysis of ClinicalTrials.gov registrations and journal publications. Journal of Clinical Epidemiology. https://doi.org/10.1016/j.jclinepi.2026.112227
Source records
- crossref · retrieved 2026-09-25T19:38:05.041Z